Groowe
/
Newsroom
/ KVRI
⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KVRI
News
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors
businesswire.com
Nov 19, 2025 2:01 PM
KVRI
RHHBY